Pfizer hires JPMorgan to weigh sale of some drugs: Bloomberg

(Reuters) - Pfizer Inc (PFE.N) is exploring sale of a group of treatments in cardiology, urology and primary care, Bloomberg reported on Thursday, citing people familiar with the matter.

The drugs could fetch more than $2 billion, Bloomberg reported. (http://bloom.bg/2kWj1q1)

Pfizer is working with financial adviser JPMorgan Chase & Co for the potential portfolio sale and the process is at a preliminary stage, Bloomberg said.

Pfizer could not be immediately reached for comment.

(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Savio D'Souza)